These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20821329)

  • 1. Can localised (19)F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response?
    McIntyre DJ; Howe FA; Ladroue C; Lofts F; Stubbs M; Griffiths JR
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):29-36. PubMed ID: 20821329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 19F-magnetic resonance spectroscopy in patients with liver metastases of colorectal cancer treated with 5-fluorouracil.
    Kamm YJ; Heerschap A; van den Bergh EJ; Wagener DJ
    Anticancer Drugs; 2004 Mar; 15(3):229-33. PubMed ID: 15014355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues of normal tissue toxicity in patient and animal studies--effect of carbogen breathing in rats after 5-fluorouracil treatment.
    Griffiths JR; McIntyre DJ; Howe FA; McSheehy PM; Ojugo ASE ; Rodrigues LM; Wadsworth P; Price NM; Lofts F; Nicholson G; Smid K; Noordhuis P; Peters GJ; Stubbs M
    Acta Oncol; 2001; 40(5):609-14. PubMed ID: 11669333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours.
    McSheehy PM; Port RE; Rodrigues LM; Robinson SP; Stubbs M; van der Borns K; Peters GJ; Judson IR; Leach MO; Griffiths JR
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):117-28. PubMed ID: 15592719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma.
    Peters GJ; Lankelma J; Kok RM; Noordhuis P; van Groeningen CJ; van der Wilt CL; Meyer S; Pinedo HM
    Cancer Chemother Pharmacol; 1993; 31(4):269-76. PubMed ID: 8422689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength.
    van Laarhoven HW; Klomp DW; Kamm YJ; Punt CJ; Heerschap A
    Cancer Res; 2003 Nov; 63(22):7609-12. PubMed ID: 14633676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa.
    Harte RJ; Matthews JC; O'Reilly SM; Tilsley DW; Osman S; Brown G; Luthra SJ; Brady F; Jones T; Price PM
    J Clin Oncol; 1999 May; 17(5):1580-8. PubMed ID: 10334547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo.
    Lemaire LP; McSheehy PM; Griffiths JR
    Cancer Chemother Pharmacol; 1998; 42(3):201-9. PubMed ID: 9685055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of localized 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver.
    Klomp DW; Van Laarhoven HW; Kentgens AP; Heerschap A
    Magn Reson Med; 2003 Aug; 50(2):303-8. PubMed ID: 12876706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer.
    Jodrell DI; Stewart M; Aird R; Knowles G; Bowman A; Wall L; McLean C
    Br J Cancer; 2001 Mar; 84(5):600-3. PubMed ID: 11237378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients.
    Gupta N; Saleem A; Kötz B; Osman S; Aboagye EO; Phillips R; Vernon C; Wasan H; Jones T; Hoskin PJ; Price PM
    Clin Cancer Res; 2006 May; 12(10):3115-23. PubMed ID: 16707610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human tumor fluorouracil trapping: clinical correlations of in vivo 19F nuclear magnetic resonance spectroscopy pharmacokinetics.
    Presant CA; Wolf W; Albright MJ; Servis KL; Ring R; Atkinson D; Ong RL; Wiseman C; King M; Blayney D
    J Clin Oncol; 1990 Nov; 8(11):1868-73. PubMed ID: 2230874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of fluorouracil uptake in human colorectal and gastric cancers by interferon or by high-dose methotrexate: An in vivo human study using noninvasive (19)F-magnetic resonance spectroscopy.
    Presant CA; Wolf W; Waluch V; Wiseman CL; Weitz I; Shani J
    J Clin Oncol; 2000 Jan; 18(2):255-61. PubMed ID: 10637237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil.
    Moehler M; Dimitrakopoulou-Strauss A; Gutzler F; Raeth U; Strauss LG; Stremmel W
    Cancer; 1998 Jul; 83(2):245-53. PubMed ID: 9669806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil.
    van Laarhoven HW; Klomp DW; Rijpkema M; Kamm YL; Wagener DJ; Barentsz JO; Punt CJ; Heerschap A
    NMR Biomed; 2007 Apr; 20(2):128-40. PubMed ID: 17006886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo.
    McSheehy PM; Robinson SP; Ojugo AS; Aboagye EO; Cannell MB; Leach MO; Judson IR; Griffiths JR
    Cancer Res; 1998 Mar; 58(6):1185-94. PubMed ID: 9515804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive 19F-NMRS of 5-fluorouracil in pharmacokinetics and pharmacodynamic studies.
    Wolf W; Waluch V; Presant CA
    NMR Biomed; 1998 Nov; 11(7):380-7. PubMed ID: 9859944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
    Findlay M; Young H; Cunningham D; Iveson A; Cronin B; Hickish T; Pratt B; Husband J; Flower M; Ott R
    J Clin Oncol; 1996 Mar; 14(3):700-8. PubMed ID: 8622014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data.
    Chazal M; Cheradame S; Formento JL; Francoual M; Formento P; Etienne MC; François E; Richelme H; Mousseau M; Letoublon C; Pezet D; Cure H; Seitz JF; Milano G
    Clin Cancer Res; 1997 Apr; 3(4):553-7. PubMed ID: 9815719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil.
    Cascinu S; Aschele C; Barni S; Debernardis D; Baldo C; Tunesi G; Catalano V; Staccioli MP; Brenna A; Muretto P; Catalano G
    Clin Cancer Res; 1999 Aug; 5(8):1996-9. PubMed ID: 10473077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.